glp-1 weight loss scarsdale and injections Basking Ridge GLP-1 Weight-Loss Treatment in Westchester

Its approved for weight loss in adults with obesity or overweight

In the larger SELECT trial in 2023, patients with heart failure, atherosclerotic disease, and overweight or obesity, treated with semaglutide 2.4 mg showed reduction in major adverse cardiac events (MACE) and heart failure end points regardless of heart failure subgroup being HFrEF or HFpEF [56,57,58]

Thats where lifestyle modifications come in, Shapiro says

The study demonstrated a safety and tolerability profile consistent with other GLP-1-based treatments

The addition of phentermine, a stimulant, helps reduce hunger by influencing certain brain chemicals involved in appetite control

USP allows a 45-day Beyond Use Date